Evidence map›Paper›PMID 37112032›Full record

ArticlePolymers2023

Bio-Based Photoreversible Networks Containing Coumarin Groups for Future Medical Applications.

Iskenderbek Elchiev, Gokhan Demirci, Miroslawa El Fray

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Iskenderbek ElchievFaculty of Chemical Technology and Engineering, Department of Polymer and Biomaterials Science, West Pomeranian University of Technology, Al. Piastów 45, 71-311 Szczecin, Poland.ORCID 0000-0002-2688-8103
Gokhan DemirciFaculty of Chemical Technology and Engineering, Department of Polymer and Biomaterials Science, West Pomeranian University of Technology, Al. Piastów 45, 71-311 Szczecin, Poland.ORCID 0000-0003-0106-5407
Miroslawa El FrayFaculty of Chemical Technology and Engineering, Department of Polymer and Biomaterials Science, West Pomeranian University of Technology, Al. Piastów 45, 71-311 Szczecin, Poland.ORCID 0000-0002-2474-3517
West Pomeranian University of Technology in Szczecin · PL

Funding

National Science Center UMO-2019/33/B/ST5/01445
6 · The paper itself

Abstract

Photocurable biomaterials that can be delivered as liquids and rapidly (within seconds) cured in situ using UV light are gaining increased interest in advanced medical applications. Nowadays, fabrication of biomaterials that contain organic photosensitive compounds have become popular due to their self-crosslinking and versatile abilities of changing shape or dissolving upon external stimuli. Special attention is paid to coumarin due to its excellent photo- and thermoreactivity upon UV light irradiation. Thus, by modifying the structure of coumarin to make it reactive with a bio-based fatty acid dimer derivative, we specifically designed a dynamic network that is sensitive to UV light and able to both crosslink and re-crosslink upon variable wave lengths. A simple condensation reaction was applied to obtain future biomaterial suitable for injection and photocrosslinking in situ upon UV light exposure and decrosslinking at the same external stimuli but at different wave lengths. Thus, we performed the modification of 7-hydroxycoumarin and condensation with fatty acid dimer derivatives towards a photoreversible bio-based network for future medical applications.

Indexed as

coumarindimer fatty dioldynamic polymer networksphotocrosslinking

Identifiers

PMID37112032
PMCPMC10141156
OpenAlexW4365513286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.